Rexlemestrocel-L
Chronic Low Back Pain
Key Facts
About Sumitomo Pharma
Sumitomo Pharma's mission is to translate cutting-edge science into innovative therapies that address significant unmet medical needs, particularly in psychiatry and oncology. The company has achieved global recognition through its commercialized products like Latuda® (lurasidone) and is advancing a robust pipeline of next-generation modalities. Its strategy hinges on a balanced portfolio, combining revenue-generating assets with high-risk, high-reward R&D in gene therapy and radiopharmaceuticals, supported by strategic global partnerships and internal discovery capabilities.
View full company profileTherapeutic Areas
Other Chronic Low Back Pain Drugs
| Drug | Company | Phase |
|---|---|---|
| SPRINT PNS for Chronic Low Back Pain | SPR Therapeutics | Approved |
| VER-01 for Chronic Low Back Pain (CLBP) | Vertanical | Phase 3 |